FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Esterified Estrogens, USP (Menest) Tablets
Status: Discontinuation
»Therapeutic Categories:

Pfizer Pharmaceuticals (New 10/13/2016)

Company Contact Information:
800-776-3637, select option 5

Presentation Posting Date Related Information
Menest® 2.5 mg(esterified estrogens, USP) Tablets (NDC 61570-075-50) N/A Pfizer has made a business decision to permanently discontinue Menest 2.5 mg tablets.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English